Global Polyacrylamide Market Size, Share & Industry Trends Analysis Report By Product (Anionic, Cationic, and Non-ionic), By Application (Water Treatment, Oil & Gas, Paper Making), By Regional Outlook and Forecast, 2023 - 2030
The Global Polyacrylamide Market size is expected to reach $8.8 billion by 2030, rising at a market growth of 6.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 2,999.4 Kilo Tonnes, experiencing a growth of 5.6% (2019-2022).
The United States, in particular, has experienced a boom in shale gas exploration and hydraulic fracturing (fracking) activities. Polyacrylamide is used in hydraulic fracturing fluids to improve water viscosity and enhance the recovery of natural gas and oil from shale formations. The shale gas industry's growth has boosted the demand for polyacrylamide-based products. Hence, the North America region would acquire 1/4th share of the market by 2030. Some of the factors impacting the market are efficient coagulation and flocculation properties of polyacrylamide, rapid urbanization and infrastructure development, and environmental concerns related to mismanagement and poor disposal.
Polyacrylamide improves water quality by removing organic matter, color, and pollutants from water sources. This is particularly important in treating surface water, groundwater, and industrial effluents. Polyacrylamide in processes like sludge dewatering and belt press operations reduces water content in sludge, minimizing water loss and improving the overall efficiency of wastewater treatment plants. Polyacrylamide-based solutions are pivotal in sustainable water management in regions facing water scarcity. They help optimize water usage by ensuring that a larger volume of water is treated and made available for reuse or safe discharge. These factors will likely propel the future demands in the market. Additionally, Construction activities often disturb the natural landscape, leaving exposed soil vulnerable to erosion by wind and water. Polyacrylamide-based erosion control products, such as erosion control blankets and hydroseeding solutions, help stabilize the soil by binding soil particles together and preventing them from being washed away. These products are particularly useful on construction sites with slopes and areas prone to runoff. In arid and semi-arid regions, construction activities can generate significant dust pollution. Polyacrylamide is used as a dust suppressant to control airborne dust particles. It binds fine soil particles, reducing dust emissions and improving air quality on construction sites. Polyacrylamide-based solutions stabilize slopes by reinforcing the soil, reducing the risk of soil movement, and ensuring the safety of infrastructure and nearby communities. These factors will propel the demand for polyacrylamides in the upcoming years.
However, the environmental impact of polyacrylamides (PAMs), mainly when not managed or disposed of properly, is a significant concern. Polyacrylamides are synthetic polymers typically non-biodegradable, meaning they do not break down naturally in the environment over short periods. This characteristic can lead to long-lasting pollution if not managed properly. Although PAMs are generally considered non-toxic, their breakdown products or contaminants present in PAM formulations can pose risks to aquatic life and ecosystems. This can include issues related to oxygen depletion, altered water chemistry, and potential harm to aquatic organisms. Therefore, these factors can negatively impact the market in the future.
Product Outlook
Based on product, the market is segmented into anionic, cationic, and non-ionic. In 2022, the cationic segment garnered a significant revenue share in the market. Cationic polyacrylamides are extensively used in water and wastewater treatment processes. Their positively charged nature allows them to effectively bind with negatively charged particles and contaminants in water, such as suspended solids, organic matter, and pollutants. As ecological regulations become more stringent globally, the demand for efficient water treatment solutions has risen, and cationic polyacrylamides have proven effective in improving the quality of treated water. Owing to these factors, the cationic segment will proliferate in the upcoming years.
Application Outlook
On the basis of application, the market is divided into water treatment, oil & gas, paper making, and others. The water treatment segment recorded the maximum revenue share in the market in 2022. Governments and environmental agencies worldwide have implemented stringent regulations on water quality and wastewater discharge. This has prompted industries and municipalities to invest in advanced water treatment processes, where polyacrylamides are crucial in removing impurities and contaminants. As a result, the demand in the segment is expected to increase in the future.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific segment acquired a considerable revenue share in the market. The demand for polyacrylamides in water and wastewater treatment will remain strong in APAC. As population growth, urbanization, and industrialization continue, the need for adequate water purification and treatment solutions increases. Polyacrylamides are essential in flocculation and sedimentation processes for water clarification. As a result, there will be an increased demand in this regional market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Anhui Jucheng Fine Chemicals Co., LTD, Ashland, Inc., BASF SE, Kemira Oyj, SNF Group, Black Rose Industries Ltd., Shandong Baomo Biochemical Co., Ltd., Xitao Polymer Co., Ltd., The Dow Chemical Company (Dow Corning Ltd.), and Solvay SA.
Scope of the Study
Market Segments covered in the Report:
By Product (Volume, Kilo Tonnes, USD Million, 2019-2030)
- Anionic
- Cationic
- Non-ionic
- Water Treatment
- Oil & Gas
- Paper Making
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Anhui Jucheng Fine Chemicals Co., LTD
- Ashland, Inc.
- BASF SE
- Kemira Oyj
- SNF Group
- Black Rose Industries Ltd.
- Shandong Baomo Biochemical Co., Ltd.
- Xitao Polymer Co., Ltd.
- The Dow Chemical Company (Dow Corning Ltd.)
- Solvay SA
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Pigmentation Disorder Treatment Market, by Type
- 1.4.2 Global Pigmentation Disorder Treatment Market, by Treatment
- 1.4.3 Global Pigmentation Disorder Treatment Market, by Distribution Channel
- 1.4.4 Global Pigmentation Disorder Treatment Market, by Geography
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter Five Forces Analysis
- Chapter 4. Global Pigmentation Disorder Treatment Market, By Type
- 4.1 Global Vitiligo Market, By Region
- 4.2 Global Melasma Market, By Region
- 4.3 Global Others Market, By Region
- Chapter 5. Global Pigmentation Disorder Treatment Market, By Treatment
- 5.1 Global Corticosteroids Market, By Region
- 5.2 Global Calcineurin Inhibitor Market, By Region
- 5.3 Global Others Market, By Region
- Chapter 6. Global Pigmentation Disorder Treatment Market, By Distribution Channel
- 6.1 Global Drug Store & Retail Pharmacies Market, By Region
- 6.2 Global Hospital Pharmacies Market, By Region
- 6.3 Global Online Pharmacies Market, By Region
- Chapter 7. Global Pigmentation Disorder Treatment Market, By Region
- 7.1 North America Pigmentation Disorder Treatment Market
- 7.1.1 North America Pigmentation Disorder Treatment Market, By Type
- 7.1.1.1 North America Vitiligo Market, By Country
- 7.1.1.2 North America Melasma Market, By Country
- 7.1.1.3 North America Others Market, By Country
- 7.1.2 North America Pigmentation Disorder Treatment Market, By Treatment
- 7.1.2.1 North America Corticosteroids Market, By Country
- 7.1.2.2 North America Calcineurin Inhibitor Market, By Country
- 7.1.2.3 North America Others Market, By Country
- 7.1.3 North America Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.1.3.1 North America Drug Store & Retail Pharmacies Market, By Country
- 7.1.3.2 North America Hospital Pharmacies Market, By Country
- 7.1.3.3 North America Online Pharmacies Market, By Country
- 7.1.4 North America Pigmentation Disorder Treatment Market, By Country
- 7.1.4.1 US Pigmentation Disorder Treatment Market
- 7.1.4.1.1 US Pigmentation Disorder Treatment Market, By Type
- 7.1.4.1.2 US Pigmentation Disorder Treatment Market, By Treatment
- 7.1.4.1.3 US Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.1.4.2 Canada Pigmentation Disorder Treatment Market
- 7.1.4.2.1 Canada Pigmentation Disorder Treatment Market, By Type
- 7.1.4.2.2 Canada Pigmentation Disorder Treatment Market, By Treatment
- 7.1.4.2.3 Canada Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.1.4.3 Mexico Pigmentation Disorder Treatment Market
- 7.1.4.3.1 Mexico Pigmentation Disorder Treatment Market, By Type
- 7.1.4.3.2 Mexico Pigmentation Disorder Treatment Market, By Treatment
- 7.1.4.3.3 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.1.4.4 Rest of North America Pigmentation Disorder Treatment Market
- 7.1.4.4.1 Rest of North America Pigmentation Disorder Treatment Market, By Type
- 7.1.4.4.2 Rest of North America Pigmentation Disorder Treatment Market, By Treatment
- 7.1.4.4.3 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2 Europe Pigmentation Disorder Treatment Market
- 7.2.1 Europe Pigmentation Disorder Treatment Market, By Type
- 7.2.1.1 Europe Vitiligo Market, By Country
- 7.2.1.2 Europe Melasma Market, By Country
- 7.2.1.3 Europe Others Market, By Country
- 7.2.2 Europe Pigmentation Disorder Treatment Market, By Treatment
- 7.2.2.1 Europe Corticosteroids Market, By Country
- 7.2.2.2 Europe Calcineurin Inhibitor Market, By Country
- 7.2.2.3 Europe Others Market, By Country
- 7.2.3 Europe Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.3.1 Europe Drug Store & Retail Pharmacies Market, By Country
- 7.2.3.2 Europe Hospital Pharmacies Market, By Country
- 7.2.3.3 Europe Online Pharmacies Market, By Country
- 7.2.4 Europe Pigmentation Disorder Treatment Market, By Country
- 7.2.4.1 Germany Pigmentation Disorder Treatment Market
- 7.2.4.1.1 Germany Pigmentation Disorder Treatment Market, By Type
- 7.2.4.1.2 Germany Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.1.3 Germany Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.4.2 UK Pigmentation Disorder Treatment Market
- 7.2.4.2.1 UK Pigmentation Disorder Treatment Market, By Type
- 7.2.4.2.2 UK Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.2.3 UK Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.4.3 France Pigmentation Disorder Treatment Market
- 7.2.4.3.1 France Pigmentation Disorder Treatment Market, By Type
- 7.2.4.3.2 France Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.3.3 France Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.4.4 Russia Pigmentation Disorder Treatment Market
- 7.2.4.4.1 Russia Pigmentation Disorder Treatment Market, By Type
- 7.2.4.4.2 Russia Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.4.3 Russia Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.4.5 Spain Pigmentation Disorder Treatment Market
- 7.2.4.5.1 Spain Pigmentation Disorder Treatment Market, By Type
- 7.2.4.5.2 Spain Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.5.3 Spain Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.4.6 Italy Pigmentation Disorder Treatment Market
- 7.2.4.6.1 Italy Pigmentation Disorder Treatment Market, By Type
- 7.2.4.6.2 Italy Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.6.3 Italy Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2.4.7 Rest of Europe Pigmentation Disorder Treatment Market
- 7.2.4.7.1 Rest of Europe Pigmentation Disorder Treatment Market, By Type
- 7.2.4.7.2 Rest of Europe Pigmentation Disorder Treatment Market, By Treatment
- 7.2.4.7.3 Rest of Europe Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3 Asia Pacific Pigmentation Disorder Treatment Market
- 7.3.1 Asia Pacific Pigmentation Disorder Treatment Market, By Type
- 7.3.1.1 Asia Pacific Vitiligo Market, By Country
- 7.3.1.2 Asia Pacific Melasma Market, By Country
- 7.3.1.3 Asia Pacific Others Market, By Country
- 7.3.2 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
- 7.3.2.1 Asia Pacific Corticosteroids Market, By Country
- 7.3.2.2 Asia Pacific Calcineurin Inhibitor Market, By Country
- 7.3.2.3 Asia Pacific Others Market, By Country
- 7.3.3 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market, By Country
- 7.3.3.2 Asia Pacific Hospital Pharmacies Market, By Country
- 7.3.3.3 Asia Pacific Online Pharmacies Market, By Country
- 7.3.4 Asia Pacific Pigmentation Disorder Treatment Market, By Country
- 7.3.4.1 China Pigmentation Disorder Treatment Market
- 7.3.4.1.1 China Pigmentation Disorder Treatment Market, By Type
- 7.3.4.1.2 China Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.1.3 China Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.4.2 Japan Pigmentation Disorder Treatment Market
- 7.3.4.2.1 Japan Pigmentation Disorder Treatment Market, By Type
- 7.3.4.2.2 Japan Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.2.3 Japan Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.4.3 India Pigmentation Disorder Treatment Market
- 7.3.4.3.1 India Pigmentation Disorder Treatment Market, By Type
- 7.3.4.3.2 India Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.3.3 India Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.4.4 South Korea Pigmentation Disorder Treatment Market
- 7.3.4.4.1 South Korea Pigmentation Disorder Treatment Market, By Type
- 7.3.4.4.2 South Korea Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.4.3 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.4.5 Singapore Pigmentation Disorder Treatment Market
- 7.3.4.5.1 Singapore Pigmentation Disorder Treatment Market, By Type
- 7.3.4.5.2 Singapore Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.5.3 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.4.6 Malaysia Pigmentation Disorder Treatment Market
- 7.3.4.6.1 Malaysia Pigmentation Disorder Treatment Market, By Type
- 7.3.4.6.2 Malaysia Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.6.3 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3.4.7 Rest of Asia Pacific Pigmentation Disorder Treatment Market
- 7.3.4.7.1 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type
- 7.3.4.7.2 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
- 7.3.4.7.3 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4 LAMEA Pigmentation Disorder Treatment Market
- 7.4.1 LAMEA Pigmentation Disorder Treatment Market, By Type
- 7.4.1.1 LAMEA Vitiligo Market, By Country
- 7.4.1.2 LAMEA Melasma Market, By Country
- 7.4.1.3 LAMEA Others Market, By Country
- 7.4.2 LAMEA Pigmentation Disorder Treatment Market, By Treatment
- 7.4.2.1 LAMEA Corticosteroids Market, By Country
- 7.4.2.2 LAMEA Calcineurin Inhibitor Market, By Country
- 7.4.2.3 LAMEA Others Market, By Country
- 7.4.3 LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.3.1 LAMEA Drug Store & Retail Pharmacies Market, By Country
- 7.4.3.2 LAMEA Hospital Pharmacies Market, By Country
- 7.4.3.3 LAMEA Online Pharmacies Market, By Country
- 7.4.4 LAMEA Pigmentation Disorder Treatment Market, By Country
- 7.4.4.1 Brazil Pigmentation Disorder Treatment Market
- 7.4.4.1.1 Brazil Pigmentation Disorder Treatment Market, By Type
- 7.4.4.1.2 Brazil Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.1.3 Brazil Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.4.2 Argentina Pigmentation Disorder Treatment Market
- 7.4.4.2.1 Argentina Pigmentation Disorder Treatment Market, By Type
- 7.4.4.2.2 Argentina Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.2.3 Argentina Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.4.3 UAE Pigmentation Disorder Treatment Market
- 7.4.4.3.1 UAE Pigmentation Disorder Treatment Market, By Type
- 7.4.4.3.2 UAE Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.3.3 UAE Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.4.4 Saudi Arabia Pigmentation Disorder Treatment Market
- 7.4.4.4.1 Saudi Arabia Pigmentation Disorder Treatment Market, By Type
- 7.4.4.4.2 Saudi Arabia Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.4.3 Saudi Arabia Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.4.5 South Africa Pigmentation Disorder Treatment Market
- 7.4.4.5.1 South Africa Pigmentation Disorder Treatment Market, By Type
- 7.4.4.5.2 South Africa Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.5.3 South Africa Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.4.6 Nigeria Pigmentation Disorder Treatment Market
- 7.4.4.6.1 Nigeria Pigmentation Disorder Treatment Market, By Type
- 7.4.4.6.2 Nigeria Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.6.3 Nigeria Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4.4.7 Rest of LAMEA Pigmentation Disorder Treatment Market
- 7.4.4.7.1 Rest of LAMEA Pigmentation Disorder Treatment Market, By Type
- 7.4.4.7.2 Rest of LAMEA Pigmentation Disorder Treatment Market, By Treatment
- 7.4.4.7.3 Rest of LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
- Chapter 8. Company Profiles
- 8.1 Bausch Health Companies Inc
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Glenmark Pharmaceuticals Limited
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 SWOT Analysis
- 8.3 Obagi Cosmeceuticals LLC
- 8.3.1 Company Overview
- 8.3.2 SWOT Analysis
- 8.4 AbbVie, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expense
- 8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 SWOT Analysis
- 8.6 Incyte Corporation
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Research & Development Expenses
- 8.6.3.1 Acquisition and Mergers:
- 8.6.3.2 Trials and Approvals:
- 8.6.4 SWOT Analysis
- 8.7 Dr. Reddy’s Laboratories Ltd.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
- 8.8 Galderma S.A.
- 8.8.1 Company Overview
- 8.9 Viatris, Inc. (Mylan N.V.)
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
- 8.10. Pfizer, Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional & Segmental Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis
- Chapter 9. Winning imperatives of Pigmentation Disorder Treatment Market
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook